Bausch + Lomb Corporation is projected to rise to $20.22 by 2027, a +25% move from its current price of $16.23. BLCO is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/12/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 13 | $16.00 | $16.24 | $16.49 | +0.07% |
| Jul 14 | $15.91 | $16.25 | $16.60 | +0.13% |
| Jul 15 | $15.84 | $16.26 | $16.69 | +0.20% |
| Jul 16 | $15.79 | $16.27 | $16.77 | +0.27% |
| Jul 17 | $15.75 | $16.28 | $16.84 | +0.33% |
| Jul 18 | $15.71 | $16.29 | $16.91 | +0.40% |
| Jul 19 | $15.67 | $16.31 | $16.97 | +0.46% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $15.67 | $16.31 | $16.97 | +0.46% |
| Week 2 | $15.48 | $16.38 | $17.33 | +0.93% |
| Week 3 | $15.36 | $16.46 | $17.63 | +1.40% |
| Week 4 | $15.27 | $16.53 | $17.90 | +1.87% |
| Week 5 | $15.20 | $16.61 | $18.16 | +2.35% |
| Week 6 | $15.14 | $16.69 | $18.40 | +2.82% |
| Week 7 | $15.09 | $16.77 | $18.63 | +3.30% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Bausch + Lomb Corporation is an eye health company that operates in the United States, Puerto Rico, China, France, Japan, Germany, the United Kingdom, Canada, Russia, Spain, Italy, Mexico, Poland, and internationally. It operates in three segments: Vision Care, Pharmaceuticals, and Surgical. The Vision Care segment provides contact lenses across daily disposable and frequently replaced modalities, including therapeutic lenses that address healing, and it also offers contact lens care products, eye vitamins, mineral supplements, and over-the-counter eye drops for eye allergies, conjunctivitis, dry eye, and redness relief.
The Pharmaceuticals segment offers proprietary and generic products for post-operative treatments and for glaucoma, ocular inflammation, ocular hypertension, dry eyes, and retinal diseases. The Surgical segment provides medical device equipment, consumables, and technologies for cataract, corneal, vitreous, and retinal eye conditions; and intraocular lenses and delivery systems, phacoemulsification equipment, and other surgical instruments and devices for cataract surgery. Bausch + Lomb was founded in 1853 and is headquartered in Vaughan, Canada, and operates as a subsidiary of Bausch Health Companies Inc.
Bausch + Lomb Corporation trades as BLCO and is categorized within Healthcare. It currently shows a price of $16.32 with a market capitalization of $5.82B and a rank of 1265. The stock sits in a 30-day trading range and has a bullish technical posture with a balanced near-term path.”
A major floor 15.1% below — a decisive break under it would weaken the trend.
The nearest floor, 8.4% below — buyers have tended to step in here.
The nearest ceiling, 5.7% above — a clean break opens room to run.
A major ceiling 13.3% above — clearing it would confirm fresh momentum.
Key BLCO support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of BLCO market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $16.77 | Sell | $16.60 | Sell |
| MA 10 | $16.70 | Sell | $16.50 | Sell |
| MA 20 | $15.94 | Buy | $16.21 | Buy |
| MA 50 | $15.86 | Buy | $16.03 | Buy |
| MA 100 | $16.31 | Sell | $16.10 | Buy |
| MA 200 | $16.22 | Buy | $16.00 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 52.17 | Neutral |
| Stoch RSI (14) | 39.19 | Neutral |
| CCI (20) | 25.46 | Neutral |
| Williams %R (14) | -41.70 | Info |
| MACD (12,26,9) | 0.07 | Buy |
| ROC (12) | 6.50 | Buy |
| Bollinger %B (20,2) | 0.59 | Neutral |
| Stochastic %K (14) | 58.30 | Neutral |
| TRIX (15) | 0.22 | Buy |
| Awesome (5,34) | 1.01 | Buy |
| Ultimate (7,14,28) | 50.58 | Neutral |
| Momentum (10) | 0.32 | Buy |
| Aroon Osc (25) | 40.00 | Buy |
| Hull MA (9) | 16.63 | Sell |
| ADX (14) | 23.76 | Buy |
| ATR (14) | 0.22 | Info |
The sentiment is BULLISH with an RSI of 60. The SMA50 is $15.75 and the SMA200 is $16.15, suggesting a bias to the upside while staying near long-run averages. The stock’s nearest support sits at $14.86 and resistance at $16.32, shaping a tight near-term framework.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $14.86 | $16.23 | $22.12 | 0% | Neutral | |
| $16.56 | $20.22 | $25.81 | +25% | Bullish | |
| $17.44 | $21.70 | $28.44 | +34% | Bullish | |
| $18.09 | $22.85 | $30.59 | +41% | Bullish | |
| $19.64 | $25.14 | $34.27 | +55% | Bullish | |
| $20.56 | $26.64 | $36.88 | +64% | Bullish | |
| $23.91 | $31.34 | $44.01 | +93% | Bullish | |
| $28.08 | $37.18 | $52.89 | +129% | Bullish | |
| $27.95 | $37.38 | $53.81 | +130% | Bullish | |
| $28.63 | $38.65 | $56.26 | +138% | Bullish | |
| $40.91 | $57.60 | $87.86 | +255% | Bullish | |
| $70.81 | $106.93 | $174.85 | +559% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $14.86 | $16.23 | $19.11 | +0.00% |
| August 2026 | $14.10 | $16.50 | $19.73 | +1.66% |
| September 2026 | $14.66 | $17.24 | $20.78 | +4.49% |
| October 2026 | $14.85 | $17.54 | $21.27 | +1.71% |
| November 2026 | $14.81 | $17.55 | $21.41 | +0.09% |
| December 2026 | $15.18 | $18.05 | $22.12 | +2.81% |
Click any year to see its month-by-month BLCO forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
The BLCO price prediction for 2026 points to an average of $16.23 (low $14.86, high $22.12) — a potential gain of 0% on today's $16.23. A consolidation phase looks the most probable path here.
In 2027, BLCO is projected to trade between $16.56 and $25.81, averaging $20.22 — a potential gain of +25% from today's $16.23. That is up +25% on the projected 2026 average. Momentum favours further upside here.
Bausch + Lomb Corporation's 2028 outlook centres on $21.70, within a $17.44 to $28.44 range. That is up +7% on the projected 2027 average. That marks a +34% change versus current levels. Buyers look set to stay in control over this stretch.
By 2029, BLCO could reach as high as $30.59, with a base case around $22.85 and support toward $18.09 — roughly +41% from $16.23. Momentum favours further upside here.
Expect BLCO to range from $19.64 to $34.27 through 2030. The $25.14 average target implies a +55% move from current prices. That is up +10% on the projected 2029 average. Buyers look set to stay in control over this stretch.
The BLCO price prediction for 2031 points to an average of $26.64 (low $20.56, high $36.88) — a potential gain of +64% on today's $16.23. Momentum favours further upside here.
In 2032, BLCO is projected to trade between $23.91 and $44.01, averaging $31.34 — a potential gain of +93% from today's $16.23. That is up +18% on the projected 2031 average. Buyers look set to stay in control over this stretch.
Bausch + Lomb Corporation's 2033 outlook centres on $37.18, within a $28.08 to $52.89 range. That is up +19% on the projected 2032 average. That marks a +129% change versus current levels. Momentum favours further upside here.
By 2034, BLCO could reach as high as $53.81, with a base case around $37.38 and support toward $27.95 — roughly +130% from $16.23. Buyers look set to stay in control over this stretch.
Expect BLCO to range from $28.63 to $56.26 through 2035. The $38.65 average target implies a +138% move from current prices. That is up +3% on the projected 2034 average. Momentum favours further upside here.
The BLCO price prediction for 2040 points to an average of $57.60 (low $40.91, high $87.86) — a potential gain of +255% on today's $16.23. Buyers look set to stay in control over this stretch.
In 2050, BLCO is projected to trade between $70.81 and $174.85, averaging $106.93 — a potential gain of +559% from today's $16.23. That is up +86% on the projected 2040 average. Momentum favours further upside here.
Investing $1,000 in BLCO today (≈ 61.614295 BLCO) could be worth
$6,588.69
+$5,588.69 (+559%) by 2050 · US Dollar
Based on the average projected BLCO price of $106.93 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in BLCOwould be worth at today's price.
$1,000 invested in BLCO on Jul 10, 2025 (≈ 70.422536 BLCO) would be worth
$1,142.96
+$142.96 (+14.3%) today · 1.14× · US Dollar
Based on a BLCO entry price of $14.2 vs. today's $16.23.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $17.16 | $945.8 | -5.4% |
| 1 month ago | $15.26 | $1,063.56 | +6.4% |
| 3 months ago | $16.49 | $984.23 | -1.6% |
| 6 months ago | $17.5 | $927.43 | -7.3% |
| 1 year ago | $14.2 | $1,142.96 | +14.3% |
| All time (4.2y) ago | $20 | $811.5 | -18.9% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our BLCO forecast.
Our base-case forecast reaches $32.00 around 2033.
Implied market cap at $32.00: $11.41B
The multi-year forecast shows a bullish trajectory from 2027 onward, with rising average targets and manageable upside. For 2026 the avg price is $16.32 with a min of $14.86 and a max of $22.71 and ROI of 0, suggesting a neutral near-term stance. From 2027 to 2050 the model projects steadily higher averages and increasingly large ROI, culminating in 2050 with an avg of $116.59 and a max of $190.68 and an ROI of 614.4.
Notable yearly figures include 2030 avg $25.55 (ROI 56.5), 2040 avg $61.40 (ROI 276.3), and 2050 avg $116.59 (ROI 614.4). The forecast remains bullish across 2027, 2028, 2029, 2031, 2032, 2033, 2034, 2035, and beyond, though these are estimates, not guarantees.
Tap a question to reveal the answer.
In 2030 the forecasted average price is $25.55 with a min of $19.95 and a max of $34.85, and ROI of 56.5. The sentiment for 2030 is BULLISH.
Forecasts show a bullish sentiment from 2027 onward, with the average price rising from $20.27 in 2027 to $116.59 in 2050 and ROI values increasing to 614.4. The 2026 forecast is neutral with an average of $16.32. These are estimates, not guarantees.
Yes. The forecast for 2035 shows an average of $40.81, with a min of $30.22 and a max of $59.43, and the preceding year 2034 shows $39.13 as the average. This indicates the potential to exceed $40 on a projection basis, with bullish sentiment.
The current price is $16.32 and the market cap is $5.82B. The stock is ranked 1265.
The 30-day picture is bullish with RSI 60. The stock trades above the 50-day and near the 200-day moving averages, with a 30-day range from $14.88 to $17.90. The nearest support is $14.86 and the resistance is $16.32.
Bausch + Lomb Corporation Community Discussion
0Share your Bausch + Lomb Corporation price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.